Newsquawk Logo

European Movers: Croda (CRDA LN) +2.0%, Endesa (ELE SM) +4.1%, Edenred (EDEN FP) +5.2%, Convatec (CTEC LN) +9.2%, Novo Nordisk (NOVOB DC) -3.5%, Unite (UTG LN) -7.1%, Fresenius Medical Care (FME GY) -9.8%

The earnings reports reflect a mix of performance across the European equities landscape.

Newsquawk StaffPublished On the live feed at — 4 more headlines followed before this page went public
Newsquawk headlinesUTC

Citi's equity markets positioning model notes Europe and Asia are favoured as the US Lags

China says it is open to nuclear talks in Geneva and urges the US to resume strategic stability dialogue with Russia

European Movers: Croda (CRDA LN) +2.0%, Endesa (ELE SM) +4.1%, Edenred (EDEN FP) +5.2%, Convatec (CTEC LN) +9.2%, Novo Nordisk (NOVOB DC) -3.5%, Unite (UTG LN) -7.1%, Fresenius Medical Care (FME GY) -9.8%

Shanghai Gold Exchange says it is to cut margin ratio and price limits for some gold and silver contracts from the closing settlement on February 24th

Earthquake of magnitude 5.59 strikes West Papua, Indonesia, GFZ reports

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Try the platform free
Free. No signup, no card.

Croda (CRDA LN) - FY 2025 (GBP): Revenue 1.70bln (prev. 1.63bln Y/Y), EBITDA 396mln (prev. 378mln Y/Y); expects sales in Q1 to be similar to the prior year at constant currency. (Croda)  

Endesa (ELE SM) - FY 2025 (EUR): Revenue 21.42bln (prev. 21.31bln Y/Y), EBITDA 5.76bln (exp. 5.60bln), Net income 2.2bln (exp. 2.13bln).  (Endesa) 

Edenred (EDEN FP) - FY 2025 (EUR): Revenue 2.96bln (exp. 2.95bln), EBITDA 1.36bln (exp. 1.34bln), Net Income 521mln (exp. 508mln). (Edenred)

Convatec (CTEC LN) - FY 2025 (USD): Revenue 2.44bln (exp. 2.43bln), adj. EBIT 316mln (exp. 525mln), adj. 0.086 (prev. 0.093 Y/Y). (Convatec)   

Novo Nordisk (NOVOB DC) downgraded to Hold from Buy at Kepler Cheuvreux; PT cut to DKK 280/shr (prev. DKK 400/shr)

Unite (UTG LN) - Q1 2025 (GBP): EPS 47.5p (prev. 46.6p Y/Y), Adj. Earnings 232.3mln (prev. 213.8mln Y/Y). Announced the disposal of GBP 186mln assets to USAF. 2026 Guidance: 2026/27 income expected at lower end of range for 2-3% rental growth and 93-96% occupancy  (Unite)

Fresenius Medical Care (FME GY) - Q4 2025 (EUR): Revenue 5.07bln (exp. 5.03bln, prev. 5.09bln Y/Y), Adj. Operating Income 705mln (prev. 589mln Y/Y), Adj. Op. Profit 594mln (exp. 565mln), EPS 1.44 (prev. 0.9 Y/Y). Declares dividend of EUR 1.49/shr (prev. EUR 1.44/shr). Expects rev. growth to be broadly flat in 2026. Sees 2026 Op. Profit Before Special Items on Consistent Level. (Fresenius Medical Care)

Context

Positive adjustments from Croda, Endesa, and Edenred indicate stronger-than-expected fundamentals, potentially boosting investor sentiment in those sectors. Conversely, Novo Nordisk's downgrade and Fresenius Medical Care's disappointing revenue guidance suggest challenges ahead for some companies, which could weigh on their respective stocks and related sectors.

Related headlines

The whole workspace, free to try.

Try it free
Newsquawk Logo

© 2026 Newsquawk. All rights reserved.